- Global Pharma News & Resources

Press Releases - 2019-09-03

Date Title Company
03-Sep-2019 New User Interface Dramatically Speeds Reviews/Approvals for Clinical Trial Disclosure TrialScope
03-Sep-2019 Regulus Therapeutics to Present at the H.C. Wainwright Global Investment Conference Regulus Therapeutics Inc.
03-Sep-2019 Regulus Therapeutics to Present at the H.C. Wainwright Global Investment Conference Regulus Therapeutics Inc.
03-Sep-2019 Join industry leaders at the inaugural Disruptive Technologies in Pharma conference 2020! SMi Group Ltd
03-Sep-2019 Ardigen Was Accepted Into the Prestigious TESLA Consortium Working to Improve Personalization of Immunotherapies Ardigen S.A.
03-Sep-2019 POLPHARMA Biologics S.A. ("Polpharma Biologics") today announces that it has entered a global commercialization agreement with Sandoz AG for a natalizumab biosimilar POLPHARMA Biologics S.A.
03-Sep-2019 An exclusive Aerie Pharmaceuticals speaker interview released for SMi’s Ophthalmic Drugs Conference 2019 SMi Group Ltd
03-Sep-2019 Indegene Acquires DT Associates, Provides End-to-End Enterprise Solution for Customer Excellence - From Consulting to Operations Indegene
03-Sep-2019 Inovio Pharmaceuticals to Present at Upcoming Investor Conferences Inovio Pharmaceuticals, Inc.
03-Sep-2019 CollPlant Biotechnologies Raising $5.5 Million CollPlant
03-Sep-2019 Noninvasive Cell Biomass Sensor for Multiplexed On-Line Fermentation Monitoring BugLab LLC
03-Sep-2019 What Covers You If Your Child's Cord Blood Unit Is Ineligible for Transplant? StemCyte
03-Sep-2019 Ablative Solutions Announces Positive 12-Month Results from Study Evaluating Company's Novel Therapy for Uncontrolled Hypertension Ablative Solutions
03-Sep-2019 Nanologica and Sterling partnership furthers new business venture Sterling Pharma Solutions
03-Sep-2019 Bayer appoints Marianne De Backer Head of Pharmaceuticals Business Development & Licensing and Member of Executive Committee Bayer
03-Sep-2019 Trovagene to Present at the H.C. Wainwright 21st Annual Global Investment Conference Trovagene, Inc.
03-Sep-2019 Satsuma Pharmaceuticals Announces Poster Presentations at the International Headache Congress Satsuma Pharmaceuticals, Inc.
03-Sep-2019 Aridis Pharmaceuticals Reports Phase 2 Clinical Trial Results of AR-105 for the Treatment of Ventilator-Associated Pneumonia Caused by Pseudomonas Aeruginosa Aridis Pharmaceuticals, Inc.
03-Sep-2019 KardiaMobile 6L offers world’s first FDA-cleared and CE-marked, six-lead personal ECG device based on your smartphone AliveCor
03-Sep-2019 OBI Pharma Announces U.S. FDA Clearance of IND Application for a Phase 1/2 Study of its Antibody-Drug Conjugate (ADC) targeted cancer therapy, OBI-999 OBI Pharma, Inc.